New studies confirm MAO inhibitors' efficacy in treating severe anxiety.
D000639:Amitriptyline / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D000639:Amitriptyline; D010624:Phenelzine